| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 5, 2011New Leads Add to Company's Expansive Portfolio of Innovative CRT-Related Technology Proven to Treat Heart Failure Patients
MINNEAPOLIS & SAN FRANCISCO, May 05, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA) approval and launch of the Attain Ability(R)...
-
May 3, 2011New Feature Set Includes External AC/DC Power and Temperature Monitoring for Therapeutic Hypothermia Patients
REDMOND, Wash., May 03, 2011 (BUSINESS WIRE) -- Physio-Control, Inc., a global leader in emergency medical solutions and wholly-owned subsidiary of Medtronic, Inc. (NYSE: MDT), today announced...
-
Apr 11, 2011Enlite(TM) SensorAvailable to Diabetes Patients for Continuous Glucose Monitoring in More Than 35 Countries
MINNEAPOLIS, Apr 11, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announces the launch of Enlite(TM) Sensor, the newest and most advanced glucose sensor for continuous glucose monitoring...
-
Apr 4, 2011Across Spectrum of Patients with Coronary Artery Disease, Novel Heart Device Shows Strong Results at One Year in RESOLUTE US and Two Years in RESOLUTE All Comers
NEW ORLEANS, Apr 04, 2011 (BUSINESS WIRE) -- Results of two major clinical studies presented at ACC.11 - the 60th Annual Scientific Session & Expo of the American College of Cardiology (ACC) -...
-
Apr 1, 2011Unique Sacral Nerve Stimulation Therapy Now Available for Treatment of Chronic Fecal Incontinence
MINNEAPOLIS, Apr 01, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of InterStim(R) Therapy for Bowel Control. InterStim...